Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Guillot

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Molecular Neurobiology|March 5, 2009
Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neuronsThomas S Guillot, Gary W Miller
Neurotoxicology|July 10, 2012
Parkinson's disease and the environment: beyond pesticidesW Michael Caudle, Thomas S Guillot, Carlos Lazo, et al.
Aesthetic Plastic Surgery|January 18, 2006
The cost effectiveness of three different measures of breast volumeMary Katherine Caruso, Thomas S Guillot, Tuong Nguyen, et al.
Neurotoxicology|February 8, 2012
Industrial toxicants and Parkinson's diseaseW Michael Caudle, Thomas S Guillot, Carlos R Lazo, et al.
Journal of Motor Behavior|November 5, 2008
Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosisThomas S Guillot, Seneshaw A Asress, Jason R Richardson, et al.
Toxicology and Applied Pharmacology|July 12, 2005
Pyrethroid pesticide-induced alterations in dopamine transporter functionMohamed A Elwan, Jason R Richardson, Thomas S Guillot, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|October 24, 2007
An evaluation of mesotherapy solutions for inducing lipolysis and treating celluliteMary K Caruso, Andrew T Roberts, Lionel Bissoon, et al.
Pharmacology, Biochemistry, and Behavior|August 2, 2002
Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOIMike F Hawkins, Sarah M Uzelac, Alan A Baumeister, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2010
Synapsins differentially control dopamine and serotonin releaseBrian M Kile, Thomas S Guillot, B Jill Venton, et al.
ACS Chemical Neuroscience|March 10, 2015
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityKelly M Lohr, Kristen A Stout, Amy R Dunn, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Molecular Neurobiology|March 5, 2009
Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neuronsThomas S Guillot, Gary W Miller
Neurotoxicology|July 10, 2012
Parkinson's disease and the environment: beyond pesticidesW Michael Caudle, Thomas S Guillot, Carlos Lazo, et al.
Aesthetic Plastic Surgery|January 18, 2006
The cost effectiveness of three different measures of breast volumeMary Katherine Caruso, Thomas S Guillot, Tuong Nguyen, et al.
Neurotoxicology|February 8, 2012
Industrial toxicants and Parkinson's diseaseW Michael Caudle, Thomas S Guillot, Carlos R Lazo, et al.
Journal of Motor Behavior|November 5, 2008
Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosisThomas S Guillot, Seneshaw A Asress, Jason R Richardson, et al.
Toxicology and Applied Pharmacology|July 12, 2005
Pyrethroid pesticide-induced alterations in dopamine transporter functionMohamed A Elwan, Jason R Richardson, Thomas S Guillot, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|October 24, 2007
An evaluation of mesotherapy solutions for inducing lipolysis and treating celluliteMary K Caruso, Andrew T Roberts, Lionel Bissoon, et al.
Pharmacology, Biochemistry, and Behavior|August 2, 2002
Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOIMike F Hawkins, Sarah M Uzelac, Alan A Baumeister, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2010
Synapsins differentially control dopamine and serotonin releaseBrian M Kile, Thomas S Guillot, B Jill Venton, et al.
ACS Chemical Neuroscience|March 10, 2015
Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine ToxicityKelly M Lohr, Kristen A Stout, Amy R Dunn, et al.
Pageof 3